Polypharmacy in Parkinson’s disease: is the risk of sudden death justified?
F.A. Scorza, A.C.G. de Almeida, C.A. Scorza, J. Finsterer Disciplina de Neurociência. Escola Paulista de Medicina/Universidade Federal de São Paulo (EPM/UNIFESP), São Paulo, Brasil. scorza@unifesp.br
Free PDF Download
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
F.A. Scorza, A.C.G. de Almeida, C.A. Scorza, J. Finsterer
Polypharmacy in Parkinson’s disease: is the risk of sudden death justified?
Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 6
Pages: 1790-1791
DOI: 10.26355/eurrev_202203_28321